Articles about 'LifeArc'

Rare disease research at Cambridge receives major boost with launch of two new centres

23 April 2024

Cambridge researchers will play key roles in two new centres dedicated to developing improved tests, treatments and potentially cures for thousands of people living with rare medical conditions.

Graphical representation of COVID-19 and network analysis

Scientists identify 160 new drugs that could be repurposed against COVID-19

30 June 2021

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19 clinical trials.

Cambridge leads trial to see if tapeworm drug can boost protection from COVID-19 among vulnerable

22 March 2021

UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it.

Articles about 'LifeArc'

Rare disease research at Cambridge receives major boost with launch of two new centres

Scientists identify 160 new drugs that could be repurposed against COVID-19

Cambridge leads trial to see if tapeworm drug can boost protection from COVID-19 among vulnerable

Connect with us

Study at Cambridge

About the University

Research at Cambridge